156 related articles for article (PubMed ID: 31066211)
1. Hypoxia-induced secretion stimulates breast cancer stem cell regulatory signalling pathways.
Jacobsson H; Harrison H; Hughes É; Persson E; Rhost S; Fitzpatrick P; Gustafsson A; Andersson D; Gregersson P; Magnusson Y; Ståhlberg A; Landberg G
Mol Oncol; 2019 Aug; 13(8):1693-1705. PubMed ID: 31066211
[TBL] [Abstract][Full Text] [Related]
2. Dihydrotanshinone-Induced NOX5 Activation Inhibits Breast Cancer Stem Cell through the ROS/Stat3 Signaling Pathway.
Kim SL; Choi HS; Kim JH; Jeong DK; Kim KS; Lee DS
Oxid Med Cell Longev; 2019; 2019():9296439. PubMed ID: 31019654
[TBL] [Abstract][Full Text] [Related]
3. Contrasting hypoxic effects on breast cancer stem cell hierarchy is dependent on ER-α status.
Harrison H; Rogerson L; Gregson HJ; Brennan KR; Clarke RB; Landberg G
Cancer Res; 2013 Feb; 73(4):1420-33. PubMed ID: 23248117
[TBL] [Abstract][Full Text] [Related]
4. Slug/β-catenin-dependent proinflammatory phenotype in hypoxic breast cancer stem cells.
Storci G; Bertoni S; De Carolis S; Papi A; Nati M; Ceccarelli C; Pirazzini C; Garagnani P; Ferrarini A; Buson G; Delledonne M; Fiorentino M; Capizzi E; Gruppioni E; Taffurelli M; Santini D; Franceschi C; Bandini G; Bonifazi F; Bonafé M
Am J Pathol; 2013 Nov; 183(5):1688-1697. PubMed ID: 24036252
[TBL] [Abstract][Full Text] [Related]
5. Sortilin inhibition limits secretion-induced progranulin-dependent breast cancer progression and cancer stem cell expansion.
Rhost S; Hughes É; Harrison H; Rafnsdottir S; Jacobsson H; Gregersson P; Magnusson Y; Fitzpatrick P; Andersson D; Berger K; Ståhlberg A; Landberg G
Breast Cancer Res; 2018 Nov; 20(1):137. PubMed ID: 30454027
[TBL] [Abstract][Full Text] [Related]
6. STAT3 signaling is activated preferentially in tumor-initiating cells in claudin-low models of human breast cancer.
Wei W; Tweardy DJ; Zhang M; Zhang X; Landua J; Petrovic I; Bu W; Roarty K; Hilsenbeck SG; Rosen JM; Lewis MT
Stem Cells; 2014 Oct; 32(10):2571-82. PubMed ID: 24891218
[TBL] [Abstract][Full Text] [Related]
7. Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling pathways.
Lin C; Wang L; Wang H; Yang L; Guo H; Wang X
J Cell Biochem; 2013 Sep; 114(9):2061-70. PubMed ID: 23553622
[TBL] [Abstract][Full Text] [Related]
8. Neuropilin-1 is expressed by breast cancer stem-like cells and is linked to NF-κB activation and tumor sphere formation.
Glinka Y; Mohammed N; Subramaniam V; Jothy S; Prud'homme GJ
Biochem Biophys Res Commun; 2012 Sep; 425(4):775-80. PubMed ID: 22885184
[TBL] [Abstract][Full Text] [Related]
9. Myeloid-Derived Suppressor Cells Endow Stem-like Qualities to Breast Cancer Cells through IL6/STAT3 and NO/NOTCH Cross-talk Signaling.
Peng D; Tanikawa T; Li W; Zhao L; Vatan L; Szeliga W; Wan S; Wei S; Wang Y; Liu Y; Staroslawska E; Szubstarski F; Rolinski J; Grywalska E; Stanisławek A; Polkowski W; Kurylcio A; Kleer C; Chang AE; Wicha M; Sabel M; Zou W; Kryczek I
Cancer Res; 2016 Jun; 76(11):3156-65. PubMed ID: 27197152
[TBL] [Abstract][Full Text] [Related]
10. Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways.
Ibrahim SA; Gadalla R; El-Ghonaimy EA; Samir O; Mohamed HT; Hassan H; Greve B; El-Shinawi M; Mohamed MM; Götte M
Mol Cancer; 2017 Mar; 16(1):57. PubMed ID: 28270211
[TBL] [Abstract][Full Text] [Related]
11. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
[TBL] [Abstract][Full Text] [Related]
12. HIF2α/EFEMP1 cascade mediates hypoxic effects on breast cancer stem cell hierarchy.
Kwak JH; Lee NH; Lee HY; Hong IS; Nam JS
Oncotarget; 2016 Jul; 7(28):43518-43533. PubMed ID: 27270657
[TBL] [Abstract][Full Text] [Related]
13. Semaphorin signaling via MICAL3 induces symmetric cell division to expand breast cancer stem-like cells.
Tominaga K; Minato H; Murayama T; Sasahara A; Nishimura T; Kiyokawa E; Kanauchi H; Shimizu S; Sato A; Nishioka K; Tsuji EI; Yano M; Ogawa T; Ishii H; Mori M; Akashi K; Okamoto K; Tanabe M; Tada KI; Tojo A; Gotoh N
Proc Natl Acad Sci U S A; 2019 Jan; 116(2):625-630. PubMed ID: 30587593
[TBL] [Abstract][Full Text] [Related]
14. Esculentoside A suppresses breast cancer stem cell growth through stemness attenuation and apoptosis induction by blocking IL-6/STAT3 signaling pathway.
Liu C; Dong L; Sun Z; Wang L; Wang Q; Li H; Zhang J; Wang X
Phytother Res; 2018 Nov; 32(11):2299-2311. PubMed ID: 30080291
[TBL] [Abstract][Full Text] [Related]
15. Fascin Is Critical for the Maintenance of Breast Cancer Stem Cell Pool Predominantly via the Activation of the Notch Self-Renewal Pathway.
Barnawi R; Al-Khaldi S; Majed Sleiman G; Sarkar A; Al-Dhfyan A; Al-Mohanna F; Ghebeh H; Al-Alwan M
Stem Cells; 2016 Dec; 34(12):2799-2813. PubMed ID: 27502039
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 6 mediated recruitment of mesenchymal stem cells to the hypoxic tumor milieu.
Rattigan Y; Hsu JM; Mishra PJ; Glod J; Banerjee D
Exp Cell Res; 2010 Dec; 316(20):3417-24. PubMed ID: 20633553
[TBL] [Abstract][Full Text] [Related]
17. Cytoprotective effect of neuropeptides on cancer stem cells: vasoactive intestinal peptide-induced antiapoptotic signaling.
Sastry KS; Chouchane AI; Wang E; Kulik G; Marincola FM; Chouchane L
Cell Death Dis; 2017 Jun; 8(6):e2844. PubMed ID: 28569785
[TBL] [Abstract][Full Text] [Related]
18. Glioblastoma cell line shows phenotypes of cancer stem cells in hypoxic microenvironment of spheroids.
Ohnishi K; Tani T; Tojo N; Sagara JI
Biochem Biophys Res Commun; 2021 Mar; 546():150-154. PubMed ID: 33582558
[TBL] [Abstract][Full Text] [Related]
19. JAK-STAT signalling controls cancer stem cell properties including chemotherapy resistance in myxoid liposarcoma.
Dolatabadi S; Jonasson E; Lindén M; Fereydouni B; Bäcksten K; Nilsson M; Martner A; Forootan A; Fagman H; Landberg G; Åman P; Ståhlberg A
Int J Cancer; 2019 Jul; 145(2):435-449. PubMed ID: 30650179
[TBL] [Abstract][Full Text] [Related]
20. Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells.
Kim SY; Kang JW; Song X; Kim BK; Yoo YD; Kwon YT; Lee YJ
Cell Signal; 2013 Apr; 25(4):961-9. PubMed ID: 23333246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
